Starting in February 2015, Saundra Pelletier has served as Chief Executive Officer and President and Executive Director of Evofem Biosciences, Inc., a biotechnology company focused on developing and commercializing innovative products that address unmet needs in the areas of women’s sexual and reproductive health. As Chief Executive Officer, Ms. Pelletier has been responsible for the company’s growth and evolution and led Evofem’s transition to the public market in January 2018 (NASDAQ: EVFM).
Ms. Pelletier has assembled an impressive team of seasoned pharmaceutical professionals that have a deep understanding of the women’s healthcare market and what women want and she attracted new investor capital. In total she has led equity financing rounds which have raised in excess of $120 million.
In her over 25 years of experience in the pharmaceutical industry, Ms. Pelletier has launched pharmaceutical brands worldwide and expanded indications on female healthcare brands in multiple countries. Her experience includes a comprehensive range of women’s healthcare products, cardiovascular, pain management, sleep therapies and medical devices. She has had oversight and accountability for Sales, Marketing, Operations, Medical Affairs, Regulatory Affairs, Manufacturing, Customer Service, Business Development and Strategic Partnerships.
Previously, Ms. Pelletier served as Vice President, Pharmaceuticals at Women First Healthcare. Prior to that she was with G.D. Searle and in her capacity as a corporate vice president and global franchise leader, Ms. Pelletier managed a $250 million business unit, reorganized companies from the ground up, raised $40 million in capital, managed worldwide partnerships, negotiated cost saving licensing agreements, assessed country infrastructures, developed commercialization plans and hired full scale teams, including contract sales forces.
Ms. Pelletier is a published author, coveted keynote speaker and moderator at key healthcare and political conferences worldwide. She has appeared at the Harvard School of Public Health, the Davos World Economic Forum, the Clinton Global Initiative, the MAKERS Conference, Women Deliver, the University of Virginia’s Darden School of Business, the University of Oregon’s Lundquist School of Business and the University of California, San Diego. She is a trained Climate Reality Advocate and hosted a roundtable session at the International Conference on Climate Change, held in Reykjavik, Iceland. Ms. Pelletier has been profiled by The New York Times, Inc. Magazine, Cosmopolitan, Bustle, CNN, Glamour, Marie Claire, and Vogue. She was named as a New Champion for Reproductive Health by the United Nations Foundation and was awarded the Athena San Diego’s Pinnacle Award for Life Sciences, which recognizes an extraordinary leader in the application of technical advances in life sciences to develop commercial products.